Demonstration of reversible priming of human neutrophils using platelet- activating factor

Blood

Volumn 88, Issue 11, 1996, Pages 4330-4337

  Kitchen, Elizabeth ^a   Rossi, Adriano G ^a   Condliffe, Alison M ^a   Haslett, Christopher ^a   Chilvers, Edwin R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APAFANT; CD11 ANTIGEN; CD18 ANTIGEN; CYTOCHROME C; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HYPOTONIC SOLUTION; ISOTONIC SOLUTION; MODIPAFANT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL POLARITY; CELL SHAPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST; TISSUE INJURY;

EID: 0029859916     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.11.4330.bloodjournal88114330     Document Type: Article

References (28)

1. Guthrie LA, McPhail LC, Henson PM, Johnston RB Jr: Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med 160:1656, 1984
2. Haslett C, Guthrie LA, Kopaniak MM, Johnston RJ, Henson PM: Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119:101, 1985
3. Vadas MA, Nicola N, Lopez AF, Metcalf D, Johnson G, Pereira A: Mononuclear cell-mediated enhancement of granulocyte function in man. J Immunol 133:202, 1984
4. Cross AS, Lowell GH, Palmblad J, Sadoff JC, Young L, Berger M: Mechanism of priming of human neutrophils by a soluble lymphoblastoid cell factor. J Immunol 135:2074, 1985
5. Worthen GS, Haslett C, Rees AJ, Gumbay RS, Henson JE, Henson PM: Neutrophil-mediated pulmonary vascular injury: synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am Rev Respir Dis 136:19, 1987
6. Smedly LA, Tonnesen RA, Sandhaus RA, Haslett C, Guthrie LA, Johnston RB, Henson PM, Worthen GS: Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 77:1233, 1986
7. Ichinose Y, Hara N, Ohta M, Aso H, Chikama H, Kawasaki M, Kubota I, Shimizu T, Yagawa K: Recombinant granulocyte colonystimulating factor and lipopolysaccharide maintain the phenotype of and superoxide generation by neutrophils. Infect Immun 58:1647, 1990
8. Carey LA, Albertine KH, Gee MH: In vivo endotoxin exposure increases neutrophil counts without maintenance of primed superoxide anion release in short-term cultures of sheep bone marrow. J Leukoc Biol 56:145, 1994
9. Edashige K, Watanabe Y, Sato EF, Takehara Y, Utsumi K: Reversible priming and protein-tyrosyl phosphorylation in human peripheral neutrophils under hypotonic conditions. Arch Biochem Biophys 302:343, 1993
10. 6 receptors. Br J Pharmacol 117:979, 1996
11. Savill JS, Henson PM, Haslett C: Phagocytosis of aged neutrophils by macrophages is mediated by a novel "charge-sensitive" recognition mechanism. J Clin Invest 84:1518, 1989
12. Savill JS, Dransfield I, Hogg N, Haslett C: Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343:170, 1990
13. Cole AT, Garlick NM, Galvin AM, Hawkey CJ, Robins RA: A flow cytometric method to measure shape change of human neutrophils. Clin Sci 89:549, 1995
14. Stocks SC, Kerr MA, Haslett C, Dransfield I: CD66-dependent neutrophil activation: a possible mechanism for vascular selectin-mediated regulation of neutrophil adhesion. J Leukoc Biol 58:40, 1995
15. Archer CB, Page CP, Morley J, MacDonald DM: Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (PAF-acether) in man. Br J Dermatol 112:285, 1985
16. Dent G, Ukena D, Chanez P, Sybrecht G, Barnes P: Characterization of PAF receptors on human neutrophils using the specific antagonist. WEB 2086: correlation between receptor binding and function. FEBS Lett 244:365, 1989
17. Ingraham LM, Coates TD, Allen JM, Higgins CP, Baehner RL, Boxer LA: Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood 59:1259, 1982
18. Gay JC, Beckman JK, Zaboy KA, Lukens JN: Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor. Blood 67:931, 1986
19. Roberts PJ, Pizzey AR, Khwaja A, Carver JE, Mire-Sluis AR, Linch DC: The effects of interleukin-8 on neutrophil f Met Leu Phe receptors, CD11b expression and metabolic activity, in comparison and combination with other cytokines. Br J Haematol 84:586, 1993
20. Warren JS, Mandel DM, Johnson KJ, Ward PA: Evidence for the role of platelet-activating factor in immune complex vasculitis in the rat. J Clin Invest 83:669, 1989
21. O'Flaherty JT, Redman JF, Schmitt JD, Ellis JM, Surles JR, Marx MH, Piantadosi C, Wykle RL: 1-O-alkyl-2-N-methylcarbamyl-glycerophosphocholine: A biologically potent, non-metabolizable analog of platelet activating factor. Biochem Biophys Res Commun 147:18, 1987
22. Tessner TG, O'Flaherty JT, Wykle RL: Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. J Biol Chem 264:4794, 1989
23. O'Flaherty JT, Jacobson DP, Redman JF: Regulation of platelet-activating factor receptors and the desensitization response in polymorphonuclear neutrophils. Biochem J 288:241, 1992
24. O'Flaherty JT, Surles JR, Redman J, Jacobson D, Piantadosi C, Wykle RL: Binding and metabolism of platelet-activating factor by human neutrophils. J Clin Invest 78:381, 1986
25. O'Flaherty JT, Chabot MC, Redman J, Jacobson D, Wykle RL: Receptor-independent metabolism of platelet-activating factor in myelogenous cells. FEBS Lett 250:341, 1989
26. Lee A, Whyte MKB, Haslett C: Prolongation of in vitro lifespan and functional longevity of neutrophils by inflammatory mediators acting through inhibition of apoptosis. J Leukoc Biol 54:283, 1993
27. Hill ME, Bird ID, Daniels RH, Elmore MA, Finnen MJ: Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 β-treated endothelial monolayers. J Immunol 153:3673, 1994
28. Nourshargh S, Larkin SW, Das A, Williams TJ: Interleukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor. Blood 85:2553, 1995